Home Crystal structure of (5S,6E,8E,10E,13R,15S,16Z)-15,5,13,15-tetrahydroxy-16-methyl-2-aza-1(1,3)-benzenacyclononadecaphane-6,8,10,16-tetraen-3-one, C24H31NO5
Article Open Access

Crystal structure of (5S,6E,8E,10E,13R,15S,16Z)-15,5,13,15-tetrahydroxy-16-methyl-2-aza-1(1,3)-benzenacyclononadecaphane-6,8,10,16-tetraen-3-one, C24H31NO5

  • Shu-Feng Bi , Jian Chen , Qian-Nuo Bian and Pu Cui ORCID logo EMAIL logo
Published/Copyright: October 29, 2025
Become an author with De Gruyter Brill

Abstract

C24H31NO5, orthorhombic, P212121 (no. 19), a = 4.9020(10) Å, b = 17.638(4) Å, c = 24.848(5) Å, V = 2148.4(7) Å3, Z = 4, R gt (F) = 0.0751, wRref (F 2) = 0.1901, T = 293(2) K.

CCDC no.: 2466724

The molecular structure is shown in the figure. Table 1 contains the crystallographic data.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.20 × 0.10 × 0.05 mm
Wavelength: MoKα radiation (0.71073 Å)
μ: 0.09 mm−1
Diffractometer, scan mode: Nonius CAD-4, φ and ω scans
θ max, completeness: 25.3°, 100 %
N(hkl)measured, N(hkl)unique, R int: 4485, 3881, 0.078
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2112
N(param)refined: 264
Programs: Nonius, Olex2, 1 , 2 SHELX 3 , 4

1 Source of material

The title compound is a natural product, obtained by extraction and isolation from actinomycetes fermentation products. 5

2 Experimental details

The structure was treated with the Olex2 crystallographic software package, 1 , 2 solved with the SHELXT structure solution program and refined with the SHELXL 3 , 4 refinement package. Carbon-bound hydrogen atoms were placed in calculated positions and refined with riding coordinates, with U iso(H) fixed at 1.2 times of U eq(C) (Table 1).

3 Comment

Ansamycins are a family of broad-spectrum bioactive macrolactams, such as antituberculosis rifamycin, 5 antitumor maytansine 6 , 7 and Hsp90 inhibitor geldanamycin. 8 The title compound of C24H31NO5, named demethyltrienomycinol, has been reported in 2008, but no three-dimensional coordinates were deposited with the Cambridge Crystallographic Data Centre in the reported literature. 5 , 6 , 7 The structure of C24H31NO5 is composed of a 21-membered macrocyclic lactam ring including a triene moiety, which formed through an amide linkage to the 3-amino-5-hydroxybenzoic acid (AHBA) fragment. The title compound crystallizes in the orthorhombic space group P212121. The geometry of title structure was characterized with the bond angles and lengths in accordance with the literature. 8 In particular, the torsion angles of C2⋯C3⋯C4⋯C5, C21⋯N⋯C1⋯C2, O2⋯C3⋯C4⋯C5, C9⋯C10⋯C11⋯O3, O4⋯C13⋯C14⋯C15 and C16⋯C17⋯C18⋯C19, are −113.9(6)°, 169.9(4)°, 126 (3)°, −69.5(6)°, −56.2(7)° and −70.9(6)°, respectively. Furthermore, the bond lengths of O1⋯C1, O2⋯C35, C4⋯C5, O5⋯C23, C10⋯C11,C14⋯C16 and N⋯C1, are 1.248(6) Å, 1.428(6) Å, 1.330(7) Å, 1.359(6) Å, 1.501(8) Å, 1.313(7) Å, and 1.332(6) Å, coincident with the reported parameters. 9 And it was further unequivocally secured that the stereo configurations of C3, C11 and C13 are S, R and S, respectively. 10 , 11 In the crystal, the molecules are arranged in layers via hydrogen bonds O5–H⋯O2 with max D–A distance 2.9 Å and minimum angle 120°. All bond angles and lengths of the title structure are within the expected range.


Corresponding author: Pu Cui, College of Life and Environment Sciences, Huangshan University, Huangshan, 245041, People’s Republic of China, E-mail:

Acknowledgements

This work was supported by the education natural science key project of Anhui Provice (2024AH051755), and the open research project of the rural revitalization collaborative technical service center of Anhui province (Huangshan University) (XCZXZD2402).

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Conflict of interest: The authors declare no conflicts of interest regarding this article.

  3. Research funding: This work was supported by the education natural science key project of Anhui Provice (2024AH051755), and the open research project of the rural revitalization collaborative technical service center of Anhui province (Huangshan University) (XCZXZD2402).

References

1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. Olex2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

2. Bourhis, L. J.; Dolomanov, O. V.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. The Anatomy of a Comprehensive Constrained, Restrained Refinement Program for the Modern computingenvironment–Olex2 Dissected. Acta Crystallogr. 2015, 71, 59–75; https://doi.org/10.1107/s2053273314022207.Search in Google Scholar

3. Sheldrick, G. M. A Short History of Shelx. Acta Crystallogr. 2008, 64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar PubMed

4. Sheldrick, G. M. Crystal Structure Refinement with Shelxl. Acta Crystallogr. 2015, 71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

5. Kawamura, T.; Tashiro, E.; Yamamoto, K.; Shindo, K.; Imoto, M. SAR Study of a Novel Triene-ansamycin Group Compound, Quinotrierixin and Related Compounds, as Inhibitors of Erstress-Induced xbp1 Activation. J. Antibiot. 2008, 61, 303–311; https://doi.org/10.1038/ja.2008.44.Search in Google Scholar PubMed

6. Maggi, N.; Pasqualucci, C.; Ballotta, R.; Sensi, P. Rifampicin: A New Orally Active Rifamycin. Chemotherapy 1966, 11, 285–292; https://doi.org/10.1159/000220462.Search in Google Scholar PubMed

7. Cassady, J. M.; Chan, K. K.; Floss, H. G.; Leistner, E. Recent Developments in the Maytansinoid Antitumor Agents. Chem. Pharm. Bull. 2004, 52, 1–26; https://doi.org/10.1248/cpb.52.1.Search in Google Scholar PubMed

8. Kusari, P.; Kusari, S.; Eckelmann, D.; Zuhlke, S.; Kayser, O.; Spiteller, M. Cross-Species Biosynthesis of Maytansine in Maytenus Serrata. RSC Adv. 2016, 6, 10011–10016; https://doi.org/10.1039/c5ra25042k.Search in Google Scholar

9. Yamada, Y.; Tashiro, E.; Taketani, S.; Imoto, M.; Kataoka, T. Mycotrienin Ii, A Translation Inhibitor that Prevents Icam-1 Expression Induced by Pro-Inflammatory Cytokines. J. Antibiot. 2011, 64, 361–366; https://doi.org/10.1038/ja.2011.23.Search in Google Scholar PubMed

10. Whitesell, L.; Mimnaugh, E. G.; Costa, B. D.; Neckers, M. L. M.; Neckers, L. M. Inhibition of Heat Shock Protein HSP90-pp60v-src Heteroprotein Complex Formation by Benzoquinone Ansamycins: Essential Role for Stress Proteins in Oncogenic Transformation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 8324–8328; https://doi.org/10.1073/pnas.91.18.8324.Search in Google Scholar PubMed PubMed Central

11. Sun, W.; Li, Y. P.; Jin, J.; Li, Z. R.; Shan, G. Z. Crystal Structure of 17-(2′-(1′-oxa-4′-aza-heterocyclohexyl-1′-)Ethylamino)-17-Demethoxygeldanamycin Dihydrate, C34H54N4O11. Z. Kristallogr.-N. Cryst. Struct. 2015, 230, 180–182; https://doi.org/10.1515/ncrs-2014-9073.Search in Google Scholar

Received: 2025-06-27
Accepted: 2025-10-05
Published Online: 2025-10-29

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 13.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2025-0289/html
Scroll to top button